Olanzapine + fluoxetine	Control 	Parent rated self-esteem 	1305	1609	OFC-treated patients demonstrated an improvement over placebo at endpoint with respect to mean change from baseline in the patient-rated KINDL-R Self-esteem subscale score (p = 0.028), and in the parent KINDL-R ratings of emotional well-being (p = 0.020), Self-esteem (p = 0.030), and Family (p = 0.006).
Olanzapine + fluoxetine	Control 	Children's depression rating scale-revised total score improvement	1704	1790	OFC showed significant improvement (p ≤ 0.05) versus placebo on the CDRS-R total score
Olanzapine + fluoxetine	Control 	Children's depression rating scale-revised total score improvement	-1	-1	The mean change from baseline was significantly in favor of OFC compared with placebo on the CDRS-R total score (−28.4 vs −23.4; p = 0.003).
Olanzapine + fluoxetine	Control 	Parent rated emotional well being	1305	1560	OFC-treated patients demonstrated an improvement over placebo at endpoint with respect to mean change from baseline in the patient-rated KINDL-R Self-esteem subscale score (p = 0.028), and in the parent KINDL-R ratings of emotional well-being (p = 0.020),
Olanzapine + fluoxetine	Control 	Patient rated self esteem	1305	1488	OFC-treated patients demonstrated an improvement over placebo at endpoint with respect to mean change from baseline in the patient-rated KINDL-R Self-esteem subscale score (p = 0.028)
Olanzapine + fluoxetine	Control 	Parent rated self-esteem 	1490	1608	and in the parent KINDL-R ratings of emotional well-being (p = 0.020), Self-esteem (p = 0.030), and Family (p = 0.006)
Olanzapine + fluoxetine	Control 	Parent rated emotional well being	1490	1560	and in the parent KINDL-R ratings of emotional well-being (p = 0.020),
Olanzapine + fluoxetine	Control 	CDRS' depressed feelings improvement	-1	-1	Depressed feelings (11) <TAB> 4.6 (1.1) <TAB> −2.9 (0.1) <TAB> 4.5 (1.1) <TAB> −2.4 (0.2) <TAB> 0.005
Olanzapine + fluoxetine	Control 	Patient rated self esteem	1175	1609	Baseline QoL as measured by the KINDL-R was substantially impaired relative to published norms for a healthy school-based sample. OFC-treated patients demonstrated an improvement over placebo at endpoint with respect to mean change from baseline in the patient-rated KINDL-R Self-esteem subscale score (p = 0.028), and in the parent KINDL-R ratings of emotional well-being (p = 0.020), Self-esteem (p = 0.030), and Family (p = 0.006).
